Effect of hormone replacement therapy on plasma levels of the cardiovascular risk factor asymmetric dimethylarginine: a randomized, placebo-controlled 12-week study in healthy early postmenopausal women - Post, MS; Verhoeven, MO; van der Mooren, MJ; Kenemans, P; Stehouwer, CD; Teerlink, T (J Clin Endocrinol Metab., 2003)
Sep